What, Why, Where, and When: Bringing Timing to Immuno-Oncology.

Rothschilds, Adrienne M; Wittrup, K Dane

Rothschilds, Adrienne M; Wittrup, K Dane.

Afiliação

Rothschilds AM; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Wittrup KD; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: wittrup@mit.edu.

Trends Immunol ; 40(1): 12-21, 2019 01.

Article em En | MEDLINE | ID: mdl-30545676

Assuntos

Antineoplásicos/imunologia; Biomarcadores Tumorais/imunologia; Neoplasias/imunologia; Animais; Antineoplásicos/uso terapêutico; Humanos; Neoplasias/tratamento farmacológico

Palavras-chave

CTLA-4; Immuno-oncology; Immunotherapy; PD-1; Timing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google